Serum proteome changes in dengue virus-infected patients from a dengue-endemic area of India: Towards new molecular targets?

OMICS A Journal of Integrative Biology

Volumn 16, Issue 10, 2012, Pages 527-536

  Ray, Sandipan ^a   Srivastava, Rajneesh ^a   Tripathi, Karnika ^a   Vaibhav, Vineet ^a   Patankar, Swati ^a   Srivastava, Sanjeeva ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; BIOLOGICAL MARKER; HAPTOGLOBIN; HEMOPEXIN; KININOGEN; PROTEOME;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DOWN REGULATION; DRUG TARGETING; ENDEMIC DISEASE; HEMOSTASIS; HOST; HUMAN; IMMUNE RESPONSE; INDIA; INFECTION CONTROL; MALARIA FALCIPARUM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PATHOGENESIS; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; VALIDATION STUDY; WESTERN BLOTTING;

ADULT; BLOOD PROTEINS; CASE-CONTROL STUDIES; COMPLEMENT ACTIVATION; DENGUE; DENGUE VIRUS; ENDEMIC DISEASES; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INDIA; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; PROTEOME; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; YOUNG ADULT;

DENGUE VIRUS;

EID: 84867036528     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2012.0037     Document Type: Article

References (47)

1. Albuquerque, L.M., Trugilho, M.R., Chapeaurouge, A., et al. (2009). Two dimensional difference gel electrophoresis (DiGE) analysis of plasmas from dengue fever patients. J Proteome Res 8, 5431-5441.
2. Andersen, O., Vilsgaard Ravn, K., Juul Sørensen, I., Jonson, G., Holm Nielsen, E., and Svehag, S.E. (1997). Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro. Scand J Immunol 46, 331-337.
3. Avila-Aguero, M.L., Avila-Aguero, C.R., Um, S.L., Soriano-Fallas, A., Cañas-Coto, A., and Yan, S.B. (2004). Systemic host inflammatory and coagulation response in the Dengue virus primo-infection. Cytokine 27, 173-179.
4. Avirutnan, P., Hauhart, R.E., Marovich, M.A., Garred, P., Atkinson, J.P., and Diamond, M.S. (2011). Complement-mediated neutralization of dengue virus requires mannosebinding lectin. MBio.2, pii: e00276-11.
5. Avirutnan, P., Mehlhop, E., and Diamond, M.S. (2008). Complement and its role in protection and pathogenesis of flavi-virus infections. Vaccine 26, 100-107.
6. Avirutnan, P., Punyadee, N., Noisakran, S., et al. (2006). Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 193, 1078-1088.
7. Butthep, P., Bunyaratvej, A., and Bhamarapravati, N. (1993). Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 24, 246-249.
8. Bhalla, A., Sharma, N., Sharma, A., and Suri, V. (2006). Concurrent infection with dengue and malaria. Indian J Med Sci 60, 330-331.
9. Cardier, J.E., Mariño, E., Romano, E., et al. (2005). Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue. Cytokine 30, 359-365.
10. Chakravarti, A., and Kumaria, R. (2005). Eco-epidemiological analysis of dengue infection during an outbreak of dengue fever, India. Virol J 2, 32.
11. Charrel, R.N., Brouqui, P., Foucault, C., and de Lamballerie, X. (2005). Concurrent dengue and malaria. Emerg Infect Dis 11, 1153-1154.
12. Chen, J.H., Chang, Y.W., Yao, C.W., et al. (2004). Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc Natl Acad Sci USA 101, 17039-17044.
13. Denery, J.R., Nunes, A.A., and Dickerson, T.J. (2011). Characterization of differences between blood sample matrices in untargeted metabolomics. Anal Chem 83, 1040-1047.
14. Gollapalli, K., Ray, S., Srivastava, R., et al. (2012). Investigation of serum proteome alterations in human glioblastoma multiforme. Proteomics (in press: DOI 10.1002/pmic. 201200002).
15. Green, S., and Rothman, A. (2006). Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 19, 429-436.
16. Gubler, D.J., and Meltzer, M. (1999). Impact of dengue/dengue hemorrhagic fever on the developing world. Adv Virus Res 53, 35-70.
17. Guha-Sapir, D., and Schimmer, B. (2005). Dengue fever: new paradigms for a changing epidemiology. Emerg Themes Epidemiol 2, 1.
18. Huang, da.W., Sherman, B.T., and Lempicki, R.A. (2009b). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37, 1-13.
19. Huang, da.W., Sherman, B.T., and Lempicki, R.A. (2009a). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57.
20. Huang, Y.H., Liu, C.C., Wang, S.T., et al. (2001). Activation of coagulation and fibrinolysis during dengue virus infection. J Med Virol 63, 247-251.
21. Issaq, H.J., Xiao, Z., and Veenstra, T.D. (2007). Serum and plasma proteomics. Chem Rev 107, 3601-3620.
22. Kaplan, A.P., Joseph, K., and Silverberg, M. (2002). Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 109, 195-209.
23. Kassa, F.A., Shio, M.T., Bellemare, M.J., Faye, B., Ndao, M., and Olivier, M. (2011). New inflammation related biomarkers during malaria infection. PLoS One 6, e26495.
24. Kaushik, R.M., Varma, A., Kaushik, R., and Gaur, K.J. (2007). Concurrent dengue and malaria due to Plasmodium falciparum and P. vivax. Trans R Soc Trop Med Hyg 101, 1048-1050.
25. Kronenberg, F., Trenkwalder, E., Kronenberg, M.F., König P., Utermann G., and Dieplinger, H. (1998). Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein (a). Kidney Int 54, 1385-1389.
26. Kurosu, T., Chaichana, P., Yamate, M., Anantapreecha, S., and Ikuta, K. (2007). Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1. Biochem Biophys Res Commun 362, 1051-1056.
27. Ladenson, J.H., Tsai, L.M., Michael, J.M., Kessler, G., and Joist, J.H. (1974). Serum versus heparinized plasma for eighteen common chemistry tests: is serum the appropriate specimen? Am J Clin Pathol 62, 545-552.
28. Nascimento, E.J., Silva, A.M., Cordeiro, M.T., et al. (2009). Alternative complement pathway deregulation is correlated with dengue severity. PLoS One 4, e6782.
29. Nathan, M.B., Dayal-Drager, R., and Guzman, M. (2009). Dengue: Guidelines for diagnosis, treatment, prevention and control, New Edition, 2009. (WHO Press, France 2009.)
30. Quaye, I.K. (2008). Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 102, 735-742.
31. Ray, S., Kamath, K.S., Srivastava, R., et al. (2012a). Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response. J Proteomics 75, 3063-3080.
32. Ray, S., Reddy, J.P., Jain, R., Gollapalli, K., Moiyadi, A., and Srivastava, S. (2011). Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead. Proteomics 11, 2139-2161.
33. Ray, S., Renu, D., Srivastava, R., et al. (2012b). Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers. PLoS One 7, e41751. doi:10.1371/journal.pone.0041751.
34. Regoli, D., and Barabé, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol Rev 32, 1-46.
35. Shaio, M.F., Chang, F.Y., and Hou, S.C. (1992). Complement pathway activity in serum from patients with classical dengue fever. Trans R Soc Trop Med Hyg 86, 672-675.
36. Singh, M.P., Majumdar, M., Singh, G., et al. (2010). NS1 antigen as an early diagnostic marker in dengue: report from India. Diagn Microbiol Infect Dis 68, 50-54.
37. Srivastava, R., Ray, S., Vaibhav, V., et al. (2012). Serum profiling of leptospirosis patients to investigate proteomic alterations. J Proteomics (in press: 10.1016/j.jprot. 2012. 04.007).
38. Stemerman, M.B., Colton, C., and Morell, E. (1984). Perturbations of the endothelium. Prog Hemost Thromb 7, 289-324.
39. Sun, J.F., Shi, Z.X., Guo, H.C., Li, S., and Tu, C.C. (2011). Proteomic analysis of swine serum following highly virulent classical swine fever virus infection. Virol J 8, 107.
40. Tan, X.F., Wu, S.S., Li, S.P., Chen, Z., and Chen F. (2011). Alpha-1 antitrypsin is a potential biomarker for hepatitis B. Virol J 8, 274.
41. Thayan, R., Huat, T.L., See, L.L., et al. (2009). The use of two-dimension electrophoresis to identify serum biomarkers from patients with dengue haemorrhagic fever. Trans R Soc Trop Med Hyg 103, 413-419.
42. Thomas, P.D., Kejariwal, A., Guo, N., et al. (2006). Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res 34, W645-W650.
43. Wan, J., Sun, W., Li, X., et al. (2006). Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase. Proteomics 6, 2886-2894.
44. Ward, D.I. (2006). A case of fatal Plasmodium falciparum malaria complicated by acute dengue fever in East Timor. Am J Trop Med Hyg 75, 182-185.
45. World Health Organization. (2008). Dengue and dengue haemorrhagic fever. Factsheet No. 117, revised May 2008. Geneva, World Health Organization, 2008 (http://www.who.int/mediacentre/factsheets/fs117/en/).
46. World Health Organization. (1997). Dengue haemorrhagic fever: diagnosis, treatment, prevention and control, 2nd ed. WHO Press, Geneva.
47. Zimmerman, L.J., Li, M., Yarbrough, W.G., Slebos, R., and Liebler, D.C. (2012). Global stability of plasma proteomes for mass spectrometry-based analyses. Mol Cell Proteomics 11, M111.014340.